Liprotamase protease

DB16584ExperimentalProtein Based Therapies

Liprotamase protease is an anti-inflammatory indicated for a wide variety of inflammatory conditions. A medication used to treat inflammation from a number of causes.

Also known as: A. melleus protease · Aspergillus melleus protease · Promelase · Protease-S · Seaprose-S

Resolves to

Compound

UNII6435YY37C0CAS118731-97-8

Clinical / RWD

RxNorm1999473

What you can answer from here — as of April 02, 2025

3Structured indicationsCondition, population, route and combination as fields, not prose

6ContraindicationsEach with its own population and attribute set

4Marketed productsAcross 1 country and 3 labellers

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Liprotamase protease, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account